Operating

Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital

Merck & Co. Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital decreased by 28.6% to $1.61B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 56.5%, from $3.71B to $1.61B. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalHigher is better
VolatilityVolatile
First reportedQ1 2015
Last reportedQ1 2026May 4, 2026

How to read this metric

A positive value indicates cash generation through efficient working capital management, while a negative value indicates cash tied up in operations.

Detailed definition

This metric aggregates changes in working capital components, such as accounts receivable, inventory, and accounts payab...

Peer comparison

Highly comparable across all sectors; a key indicator of operational efficiency and cash conversion cycle health.

Metric ID: operating_increase_decrease_in_operating_capital

Historical Data

11 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q1 '23Q2 '23Q1 '24Q2 '24Q1 '25Q2 '25Q1 '26
Value$1.46B$139.00M$1.30B$1.40B$2.89B$1.64B$3.38B$1.01B$3.71B$2.26B$1.61B
QoQ Change-90.5%+834.5%+7.7%+106.6%-43.4%+106.7%-70.1%+266.8%-39.1%-28.6%
YoY Change-4.4%+122.5%+16.9%+17.0%-38.1%+9.8%+123.2%-56.5%
Range$139.00M$3.71B
CAGR+4.0%
Avg YoY Growth+23.8%
Median YoY Growth+13.3%
Current Streak2 quarters decline

Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital at Other Companies

Frequently Asked Questions

What is Merck & Co.'s adjustment to reconcile net income to cash provided by (used in) operating activity, increase (decrease) in operating capital?
Merck & Co. (MRK) reported adjustment to reconcile net income to cash provided by (used in) operating activity, increase (decrease) in operating capital of $1.61B in Q1 2026.
How has Merck & Co.'s adjustment to reconcile net income to cash provided by (used in) operating activity, increase (decrease) in operating capital changed year-over-year?
Merck & Co.'s adjustment to reconcile net income to cash provided by (used in) operating activity, increase (decrease) in operating capital decreased by 56.5% year-over-year, from $3.71B to $1.61B.
What does adjustment to reconcile net income to cash provided by (used in) operating activity, increase (decrease) in operating capital mean?
The net cash impact of changes in day-to-day working capital items.